Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Oramed'PlatformTech In Oral Delivery Of Proteins Gets Patent In Israel,Australia

Oramed Pharmaceuticals Inc. (ORMP: Quote), a developer of oral drug delivery systems, announced Thursday that it has received Notices of Allowance from the Israel and Australian Patent Offices.

The patent entitled, "Methods and Compositions for Oral Administrations of Proteins" covers a core concept of the company's technology for the oral delivery of drugs and vaccines currently delivered via injection.

The company stated that the allowance in Israel marks the second from the Israel Patent Office in the past 30 days. Additionally, this is Oramed's second Australian patent allowance, following the grant of a different patent in May 2012.

The company noted that the patent has also been approved in Japan, China, Russia, and New Zealand.

Click here to receive FREE breaking news email alerts for Oramed Pharmaceuticals Inc. and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After failing to sustain an initial upward move, stocks have shown a lack of direction over the course of the trading day on Friday. The Dow and the S&P 500 reached new record highs in early trading but have given back ground since then. President Barack Obama delivered a statement Thursday evening thanking members of Congress for voting to approve legislation granting the U.S. military the authority to train and arm moderate Syrian rebels fighting against the terrorist group known as the Islamic State. While the Conference Board released a report on Friday showing a continued increase by its index of leading U.S. economic indicators in the month of August, the pace of growth showed a significant slowdown compared to the previous month.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.